Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BridgeBio Pharma (BBIO) Current Leases: 2019-2025

Historic Current Leases for BridgeBio Pharma (BBIO) over the last 6 years, with Sep 2025 value amounting to $5.3 million.

  • BridgeBio Pharma's Current Leases rose 15.09% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 15.09%. This contributed to the annual value of $4.5 million for FY2024, which is 9.16% up from last year.
  • BridgeBio Pharma's Current Leases amounted to $5.3 million in Q3 2025, which was up 10.71% from $4.8 million recorded in Q2 2025.
  • BridgeBio Pharma's Current Leases' 5-year high stood at $5.3 million during Q3 2025, with a 5-year trough of $3.7 million in Q1 2023.
  • In the last 3 years, BridgeBio Pharma's Current Leases had a median value of $4.5 million in 2024 and averaged $4.5 million.
  • Per our database at Business Quant, BridgeBio Pharma's Current Leases soared by 51.67% in 2021 and then decreased by 25.58% in 2022.
  • Over the past 5 years, BridgeBio Pharma's Current Leases (Quarterly) stood at $4.9 million in 2021, then decreased by 25.58% to $3.7 million in 2022, then climbed by 12.33% to $4.1 million in 2023, then rose by 9.16% to $4.5 million in 2024, then rose by 15.09% to $5.3 million in 2025.
  • Its Current Leases was $5.3 million in Q3 2025, compared to $4.8 million in Q2 2025 and $5.2 million in Q1 2025.